Related Experiment Video

Updated: Jun 27, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors

John Porter1, Andrew Payne, Ben de Candole

  • 1UCB Celltech, 216 Bath Road, Slough, United Kingdom. john.porter@ucb-group.com

Bioorganic & Medicinal Chemistry Letters
|November 26, 2008
PubMed

Insights

Researchers developed phenyl pyrazoles that bind to anti-apoptotic Bcl-2, inhibiting tumor survival during cancer therapy. This discovery offers potential new therapeutic strategies targeting cancer cell survival mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • The anti-apoptotic protein Bcl-2 is crucial for tumor cell survival, particularly in response to chemotherapy and radiation.
  • Bcl-2 functions by inhibiting pro-apoptotic proteins within the Bcl-2 family.
  • Targeting Bcl-2 presents a promising strategy for overcoming cancer treatment resistance.

Purpose of the Study:

  • To design and synthesize novel phenyl pyrazole compounds with high affinity for Bcl-2.
  • To investigate the structure-activity relationship (SAR) of these compounds.
  • To provide structural insights into Bcl-2 inhibition using X-ray crystallography.

Main Methods:

  • Synthesis of a series of phenyl pyrazole derivatives.
  • Biochemical assays to determine binding affinity to Bcl-2.
  • X-ray crystallography to elucidate the co-crystal structure of Bcl-2 with inhibitors.

Main Results:

  • Several phenyl pyrazoles demonstrated high binding affinity for Bcl-2.
  • The study identified key structural features responsible for potent Bcl-2 inhibition.
  • X-ray crystallography revealed the binding mode of phenyl pyrazoles within the Bcl-2 binding pocket.

Conclusions:

  • Phenyl pyrazoles are effective inhibitors of Bcl-2.
  • These compounds show potential for development as anti-cancer therapeutics.
  • Structural data provides a foundation for further optimization of Bcl-2 inhibitors.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...